VETMEDIN®-CA1 (pimobendan) chewable tablets is conditionally approved
for the treatment of dogs with myxomatous mitral valve disease (MMVD) in
the pre-clinical stage B2 (asymptomatic with a murmur/abnormal heart
sounds and evidence of increased heart size) to delay onset of clinical
signs of heart failure.

▪Recommended for dogs diagnosed with Stage B2 MMVD, VETMEDIN®-CA1
(pimobendan) can be used for the delay of onset of congestive heart
failure
▪May prolong the number of symptom-free days in dogs
▪Helps dogs continue to engage in the daily activities they enjoy
▪Available as a beef-flavored, chewable tablet in 2 convenient dosing
sizes (1.25 mg and 5 mg)